Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Document And Entity Information

v3.10.0.1
Document And Entity Information
9 Months Ended
Sep. 30, 2018
Document Information [Line Items]  
Entity Registrant Name Aptose Biosciences Inc.
Entity Central Index Key 0000882361
Trading Symbol apto
Current Fiscal Year End Date --12-31
Entity Current Reporting Status Yes
Document Type 6-K
Document Period End Date Sep. 30, 2018
Document Fiscal Year Focus 2018
Document Fiscal Period Focus Q3
Amendment Flag false